Are There Therapeutic Implications for Targeting Serotonin in Cancer?
Given its role in various cancers, targeting serotonin signaling pathways offers a promising therapeutic avenue. Drugs that block specific serotonin receptors or inhibit serotonin synthesis could potentially be used to impede cancer progression. For example, serotonin antagonists have shown efficacy in preclinical models of cancer.
